Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands
Authors:
Open Access
- 20 May 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Abstract
Retrieval of circulating tumor cells (CTC) has proven valuable for assessing a patient's cancer burden, evaluating response to therapy, and analyzing which drug might treat a cancer best. Although most isolation methods retrieve CTCs based on size, shape, or capture by tumor-specific antibodies, we explore here the use of small molecule tumor-specific ligands linked to magnetic beads for CTC capture. We have designed folic acid-biotin conjugates with different linkers for the capture of folate receptor (FR) + tumor cells spiked into whole blood, and application of the same technology to isolate FR + CTCs from the peripheral blood of both tumor-bearing mice and non-small cell lung patients. We demonstrate that folic acid linked via a rigid linker to a flexible PEG spacer that is in turn tethered to a magnetic bead enables optimal CTC retrieval, reaching nearly 100% capture when 100 cancer cells are spiked into 1 mL of aqueous buffer and ~ 90% capture when the same quantity of cells is diluted into whole blood. In a live animal model, the same methodology is shown to efficiently retrieve CTCs from tumor-bearing mice, yielding cancer cell counts that are proportional to total tumor burden. More importantly, the same method is shown to collect ~ 29 CTCs/8 mL peripheral blood from patients with non-small cell lung cancer. Since the ligand-presentation strategy optimized here should also prove useful in targeting other nanoparticles to other cells, the methods described below should have general applicability in the design of nanoparticles for cell-specific targeting.Keywords
Funding Information
- Three Lake Partners, LLC
- Purdue University Center for Cancer Research
This publication has 71 references indexed in Scilit:
- Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transitionBMC Cancer, 2012
- Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based ChemotherapyInternational Journal of Gynecological Cancer, 2011
- HER2-Positive Circulating Tumor Cells in Breast CancerPLOS ONE, 2011
- Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinomaBMC Cancer, 2009
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsBreast Cancer Research and Treatment, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Prostate-Specific Membrane Antigen Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing LigandMolecular Pharmaceutics, 2009
- In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometryProceedings of the National Academy of Sciences, 2007
- Proline-induced disruption of a transmembrane α-helix in its natural environmentJournal of Molecular Biology, 1998
- Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment.Proceedings of the National Academy of Sciences, 1996